Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | XBP1 | P17861 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23964677 | 1.00 | TSHR (0.47) | TSHRMAPK1LMNANPSR1SMN1; SMN2 | |
| SCHEMBL711057 | 0.93 | TSHR (0.44) | TSHRMAPK1LMNANPSR1SMN1; SMN2 | |
| SCHEMBL711178 | 0.93 | TSHR (0.44) | TSHRMAPK1LMNANPSR1SMN1; SMN2 | |
| SCHEMBL810670 | 0.93 | TSHR (0.44) | TSHRMAPK1LMNANPSR1SMN1; SMN2 | |
| SCHEMBL19676889 | 0.89 | TSHR (0.49) | TSHRMAPK1LMNANPSR1SMN1; SMN2 | |
| SCHEMBL8423671 | 0.85 | TSHR (0.43) | TSHRMAPK1SMN1; SMN2ALDH1A1TDP1 | |
| SCHEMBL16808766 | 0.85 | TSHR (0.57) | TSHRMAPK1SMN1; SMN2HPGDALDH1A1 | |
| SCHEMBL16517868 | 0.85 | TSHR (0.57) | TSHRMAPK1SMN1; SMN2HPGDALDH1A1 | |
| SCHEMBL8426911 | 0.84 | TSHR (0.42) | TSHRMAPK1SMN1; SMN2ALDH1A1 | |
| SCHEMBL1412793 | 0.83 | TSHR (0.55) | TSHRMAPK1SMN1; SMN2HPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 226 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4547756-A1 | NANOIMPRINT LITHOGRAPHY RESIN COMPOSITION | Illumina, Inc. (US) | 2025-05-07 | — | — | EP | claimed |
| WO-2024154978-A1 | AMPHIPATHIC POLYAMIDE-BASED REVERSE OSMOSIS SEPARATION MEMBRANE WITH IMPROVED FOULING RESISTANCE AND WEAR RESISTANCE AND MANUFACTURING METHOD THEREFOR | 도레이첨단소재 주식회사 | 2024-07-25 | — | — | WO | claimed |
| US-20240018381-A1 | NANOIMPRINT LITHOGRAPHY RESIN COMPOSITION | ILLUMINA, INC. | 2024-01-18 | — | — | US | claimed |
| WO-2024003104-A1 | NANOIMPRINT LITHOGRAPHY RESIN COMPOSITION | ILLUMINA CAMBRIDGE LIMITED (GB) | 2024-01-04 | — | — | WO | claimed |
| EP-4257556-A2 | PARTICLES WITH BIOZIDAL COATING | InstrAction GmbH (DE) | 2023-10-11 | — | — | EP | claimed |
| EP-4095162-A1 | APPLICATION OF AND PREPARATION METHOD FOR CATIONIC POLYMER MODIFIED BY FLUORINE-CONTAINING COMPOUND AS DRUG CARRIER | Soochow University (CN) | 2022-11-30 | — | — | EP | claimed |
| US-20220273806-A1 | USE OF FLUORINE-CONTAINING COMPOUND-MODIFIED CATIONIC POLYMER AS DRUG CARRIER AND PREPARATION METHOD | SOOCHOW UNIVERSITY (CN) | 2022-09-01 | — | — | US | claimed |
| WO-2022093797-A1 | FUNCTIONAL EPOXIDES IN CATALYST-BASED ELECTROLYTE COMPOSITIONS FOR LI-ION BATTERIES | ENEVATE CORPORATION (US) | 2022-05-05 | — | — | WO | claimed |
| US-10975260-B2 | Monomers, polymers and coating formulations that comprise at least one N-halamine precursor, a cationic center and a coating incorporation group | UNIVERSITY OF MANITOBA (CA) | 2021-04-13 | — | — | US | claimed |
| EP-2759332-B1 | CHLORINE-RESISTANT HIGHLY PERMEABLE WATER-TREATMENT MEMBRANE, AND METHOD FOR PREPARING SAME | LG CHEMICAL LTD (KR) | 2018-01-31 | — | — | EP | claimed |
| US-20090306294-A1 | Method of producing comb block-copolymers from epoxy-functionalized nitroxylethers and anionically polymerizable monomers | CIBA SPECIALTY CHEMICALS CORP. | 2009-12-10 | — | — | US | claimed |
| EP-1877457-B1 | METHOD OF PRODUCING COMB BLOCK-COPOLYMERS FROM EPOXY-FUNCTIONALIZED NITROXYLETHERS AND ANIONICALLY POLYMERIZABLE MONOMERS | BASF SE (DE) | 2009-08-12 | — | — | EP | claimed |
| EP-1534765-B1 | METHOD OF PRODUCING COMB OR STAR COPOLYMERS USING EPOXY-FUNCTIONALIZED NITROXYLETHERS | CIBA HOLDING INC (CH) | 2008-12-17 | — | — | EP | claimed |
| EP-1877457-A1 | METHOD OF PRODUCING COMB BLOCK-COPOLYMERS FROM EPOXY-FUNCTIONALIZED NITROXYLETHERS AND ANIONICALLY POLYMERIZABLE MONOMERS | Ciba Specialty Chemicals Holding Inc. (CH) | 2008-01-16 | — | — | EP | claimed |
| US-7291682-B2 | Method of producing comb or star copolymers using epoxy-functionalized nitroxylethers | CIBA SPECIALTY CHEMICALS CORP. (US) | 2007-11-06 | — | — | US | claimed |
| WO-2006117302-A1 | METHOD OF PRODUCING COMB BLOCK-COPOLYMERS FROM EPOXY-FUNCTIONALIZED NITROXYLETHERS AND ANIONICALLY POLYMERIZABLE MONOMERS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-11-09 | — | — | WO | claimed |
| US-20060020105-A1 | Method of producing comb or star copolymers using epoxy-functionalized nitroxylethers | CIBA SPECIALTY CHEMICALS CORP. | 2006-01-26 | — | — | US | claimed |
| EP-1534765-A1 | METHOD OF PRODUCING COMB OR STAR COPOLYMERS USING EPOXY-FUNCTIONALIZED NITROXYLETHERS | Ciba SC Holding AG (CH) | 2005-06-01 | — | — | EP | claimed |
| WO-2004022617-A1 | METHOD OF PRODUCING COMB OR STAR COPOLYMERS USING EPOXY-FUNCTIONALIZED NITROXYLETHERS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2004-03-18 | — | — | WO | claimed |
| US-5710211-A | REACTION OF POLYMER WITH COMPOUND HAVING A THIOL OR THIOESTER AND HYDROLYSIS TO FORM VINYL ALCOHOL | KURARAY CO., LTD. (JP) | 1998-01-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220273806-A1 | USE OF FLUORINE-CONTAINING COMPOUND-MODIFIED CATIONIC POLYMER AS DRUG CARRIER AND PREPARATION METHOD | F12, SLCO4C1, SLC7A1 | TSHR 111/4885MAPK1 2034/4885LMNA 3432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.